Cargando…
Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review
SIMPLE SUMMARY: Even though up to 20% of patients with cancer eventually develop brain metastases (BM), most clinical trials have historically forbidden the enrolment of individuals with BM. The reasons for this practice include considerations regarding safety and efficacy, but there is a pressing n...
Autores principales: | Duchnowska, Renata, Saad, Everardo D., Banaszek, Małgorzata, Pawłowska, Ewa, Liberek, Hanna, Cichowska-Cwalińska, Natalia, Jassem, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582366/ https://www.ncbi.nlm.nih.gov/pubmed/34771468 http://dx.doi.org/10.3390/cancers13215306 |
Ejemplares similares
-
Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
por: Cichowska-Cwalińska, Natalia, et al.
Publicado: (2023) -
Molecular Profiles of Brain Metastases: A Focus on Heterogeneity
por: Ali, Shan, et al.
Publicado: (2021) -
Radiotherapy for Leptomeningeal Carcinomatosis in Breast Cancer Patients: A Narrative Review
por: Pawłowska, Ewa, et al.
Publicado: (2022) -
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number
por: Szutowicz-Zielinska, Ewa, et al.
Publicado: (2016) -
Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer
por: Hryciuk, Beata, et al.
Publicado: (2020)